PTCE - Patient Safety and Quality Assurance (23.75% of the exam) - Section 3.4

Apply event reporting procedures for medication errors, adverse effects, product integrity issues, MedWatch, VAERS, near misses, root-cause analysis (RCA), and continuous quality improvement (CQI).

Apply event reporting procedures for medication errors, near misses, and adverse effects using MedWatch for drug and device events and VAERS for vaccine-related reactions. Use root-cause analysis and continuous quality improvement principles to identify system-level causes and reduce the likelihood of recurrence.

MedWatchVAERSRoot-cause analysisContinuous quality improvement

Practice question for this objective

Free samplePatient Safety and Quality Assurancemedium

While performing the final verification, a pharmacist notices that a technician had selected metFORMIN instead of the prescribed metroNIDAZOLE for a patient, Renata Solis. The error is caught and corrected before the medicine leaves the pharmacy, so the patient is never affected. To strengthen the quality programme, what is the technician's BEST next step regarding this event?

ATake no further action, because the wrong drug never reached the patient and caused no harm.
BDocument it in the near-miss reporting system so the event can feed continuous quality improvement. Correct
CSubmit a MedWatch report, because any wrong-drug selection is a reportable adverse event.
DFile a formal complaint against the technician with the state board for the selection error.

Treat caught errors as near misses that must be documented to drive continuous quality improvement. A near miss is an error intercepted before reaching the patient; capturing it in a non-punitive reporting system supplies the data continuous quality improvement uses to redesign processes and prevent recurrence.

Why A is wrong: It is tempting to drop a caught error, but unrecorded near misses hide patterns; failing to act forfeits the chance to prevent the next, possibly uncaught, mistake.

Why B is correct: Recording near misses lets the pharmacy analyse contributing factors, such as look-alike names, and implement safeguards, which is the core purpose of a continuous quality improvement programme.

Why C is wrong: MedWatch captures adverse events and product problems that affect patients; a near miss with no patient exposure does not meet that threshold and is handled internally.

Why D is wrong: Punitive escalation discourages the open reporting that quality systems depend on; a single look-alike selection error is addressed through process review, not licensing action.

See more PTCE practice questions, answers explained.

Exam traps in Patient Safety and Quality Assurance

Answers that look right on this material and are not. Each one is a distractor from a different question in the PTCE bank for this domain.

It is the dedicated national system for reporting adverse events that follow administration of vaccines
Why it is wrong: Tempting because both are federal safety systems, but vaccine adverse events are reported through VAERS, not MedWatch.
Any harm experienced by a patient that arises only when a medicine is taken at more than the labelled dose
Why it is wrong: Restricting the definition to overdose is too narrow; an adverse drug event can occur at normal doses, so this misses the broader meaning.
The FDA MedWatch programme, because all paediatric adverse events flow through MedWatch.
Why it is wrong: MedWatch handles marketed drugs and biologics generally, but vaccine adverse events have their own dedicated system, so MedWatch is not the primary destination here.

Examworthy is not affiliated with or endorsed by PTCB. Original, blueprint-aligned practice material only.